Choice of estimated glomerular filtration rate equation impacts drug-dosing recommendations and risk stratification in patients with chronic kidney disease undergoing percutaneous coronary interventions

Journal of the American College of Cardiology

Volumn 65, Issue 25, 2015, Pages 2714-2723

  Parsh, Jessica ^a   Seth, Milan ^a   Aronow, Herbert ^b   Dixon, Simon ^c   Heung, Michael ^a   Mehran, Roxana ^d   Gurm, Hitinder S ^a,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ST JOSEPH MERCY HOSPITAL   (United States)

^c Beaumont Hospital System   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

catheterization; chronic; coronary disease; creatinine; renal insufficiency; risk assessment

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VERY ELDERLY; ADVERSE EFFECTS; CHRONIC KIDNEY FAILURE; MATHEMATICS; PATHOPHYSIOLOGY; PROCEDURES;

AGED; FEMALE; FIBRINOLYTIC AGENTS; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MATHEMATICS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT;

EID: 84937431121     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.04.037     Document Type: Article

References (25)

1. E.B. Hanna, A.Y. Chen, M.T. Roe, S.D. Wiviott, C.S. Fox, and J.R. Saucedo Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention J Am Coll Cardiol Intv 4 2011 1002 1008
2. T.T. Tsai, U.D. Patel, T.I. Chang, and et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry J Am Coll Cardiol Intv 7 2014 1 9
3. M.P. Thomas, M. Moscucci, D.E. Smith Blue Cross Blue Shield of Michigan Cardiovascular Consortium Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Clin Cardiol 34 2011 549 554
4. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
5. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth for the Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
6. A.S. Levey, L.A. Stevens, C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med 2011;155:408] Ann Intern Med 150 2009 604 612
7. E.S. Schaeffner, N. Ebert, P. Delanaye, and et al. Two novel equations to estimate kidney function in persons aged 70 years or older Ann Intern Med 157 2012 471 481
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney Int Suppl 3 2013 1 150
9. L.A. Stevens, J. Manzi, A.S. Levey, and et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database Am J Kidney Dis 50 2007 21 35
10. Miller G. Current status of reporting estimated glomerular filtration rate (eGFR). College of American Pathologists website. Available at: http://www.cap.org/apps/docs/committees/chemistry/current-status-of-reporting-eGFR.pdf. Accessed April 21, 2015.
11. H.S. Gurm, D.E. Smith, J.S. Collins Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention J Am Coll Cardiol 51 2008 529 535
12. K. Szummer, P. Lundman, S.H. Jacobson for SWEDEHEART Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) Am Heart J 159 2010 979 986
13. W.M. Michels, D.C. Grootendorst, M. Verduijn, E.G. Elliott, F.W. Dekker, and R.T. Krediet Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size Clin J Am Soc Nephrol 5 2010 1003 1009
14. D. Du Bois, and E.F. Du Bois A formula to estimate the approximate surface area if height and weight be known Arch Intern Med 17 1916 863 871
15. B.J. Devine Case number 25: gentamicin therapy Drug Intell Clin Pharm 8 1974 650 655
16. N.K. Slocum, P.M. Grossman, M. Moscucci, and et al. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Am Heart J 163 2012 829 834
17. K.J. Harjai, A. Raizada, C. Shenoy, and et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system Am J Cardiol 101 2008 812 819
18. L.I. Lin A concordance correlation coefficient to evaluate reproducibility Biometrics 45 1989 255 268
19. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
20. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12
21. DailyMed. Drug label archives. NIH U.S. National Library of Medicine website. Available at: http://dailymed.Nlm.Nih.Gov/dailymed/index.Cfm. Accessed April 21, 2015.
22. R Foundation for Statistical Computing website. The R Project for Statistical Computing. Available at: http://www.R-project.org/. Accessed April 21, 2015.
23. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [published correction appears in N Engl J Med 2008;18:4] N Engl J Med 351 2004 1296 1305
24. Chronic Kidney Disease Prognosis Consortium K. Matsushita, M. van der Velde, B.C. Astor, and et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
25. Renal Impairment Guidance Working Group. Guidance for industry: pharmacokinetics in patients with impaired renal function: study design, data analysis, and impact on dosing and labeling. Center for Drug Evaluation and Research (CDER) U.S. Department of Health and Human Services Food and Drug Administration. March 2010. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm204959.pdf. Accessed April 21, 2015.